Literature DB >> 23380719

Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosa.

Matthias Willmann1, Matthias Marschal, Florian Hölzl, Klaus Schröppel, Ingo B Autenrieth, Silke Peter.   

Abstract

The association between antimicrobial consumption and resistance in nonfermentative Gram-negative bacteria is well-known. Antimicrobial restriction, implemented in clinical routines by antibiotic stewardship programs (ASPs), is considered a means to reduce resistance rates. Whether and how antimicrobial restriction can accomplish this goal is still unknown though. This leads to an element of uncertainty when designing strategies for ASPs. From January 2002 until December 2011, an observational study was performed at the University Hospital Tübingen, Tübingen, Germany, to investigate the association between antimicrobial use and resistance rates in Pseudomonas aeruginosa. Transfer function models were used to determine such associations and to simulate antimicrobial restriction strategies. Various positive associations between antimicrobial consumption and resistance were observed in our setting. Surprisingly, impact estimations of different antimicrobial restriction strategies revealed relatively low intervention expenses to effectively attenuate the observed increase in resistance. For example, a simulated intervention of an annual 4% reduction in the use of meropenem over 3 years from 2009 until 2011 yielded a 62.5% attenuation (95% confidence interval, 15% to 110%) in the rising trend of multidrug-resistant Pseudomonas aeruginosa (three- and four-class-resistant P. aeruginosa [34MRGN-PA]). Time series analysis models derived from past data may be a tool to predict the outcome of antimicrobial restriction strategies, and could be used to design ASPs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380719      PMCID: PMC3623362          DOI: 10.1128/AAC.02142-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis.

Authors:  J M López-Lozano; D L Monnet; A Yagüe; A Burgos; N Gonzalo; P Campillos; M Saez
Journal:  Int J Antimicrob Agents       Date:  2000-02       Impact factor: 5.283

2.  Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa.

Authors:  Keith S Kaye; Zeina A Kanafani; Ashley E Dodds; John J Engemann; Stephen G Weber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain.

Authors:  Louis Valiquette; Benoit Cossette; Marie-Pierre Garant; Hassan Diab; Jacques Pépin
Journal:  Clin Infect Dis       Date:  2007-09-01       Impact factor: 9.079

4.  Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.

Authors:  Aspasia Katragkou; Maria Kotsiou; Charalampos Antachopoulos; Alexis Benos; Danai Sofianou; Maria Tamiolaki; Emmanuel Roilides
Journal:  Intensive Care Med       Date:  2006-06-21       Impact factor: 17.440

5.  Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.

Authors:  José A Martínez; Josefa Aguilar; Manel Almela; Francesc Marco; Alex Soriano; Fina López; Valentina Balasso; Laura Pozo; Josep Mensa
Journal:  J Antimicrob Chemother       Date:  2006-09-01       Impact factor: 5.790

6.  Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients.

Authors:  Anthony D Harris; Eli Perencevich; Mary-Claire Roghmann; Glenn Morris; Keith S Kaye; Judith A Johnson
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

7.  Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions.

Authors:  Adam D Lipworth; Emily P Hyle; Neil O Fishman; Irving Nachamkin; Warren B Bilker; Ann Marie Marr; Lori A Larosa; Nishaminy Kasbekar; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2006-02-23       Impact factor: 3.254

8.  Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.

Authors:  J J Rahal; C Urban; D Horn; K Freeman; S Segal-Maurer; J Maurer; N Mariano; S Marks; J M Burns; D Dominick; M Lim
Journal:  JAMA       Date:  1998-10-14       Impact factor: 56.272

9.  Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.

Authors:  Sang-Oh Lee; Nam Joong Kim; Sang-Ho Choi; Tae Hyong Kim; Jin-Won Chung; Jun-Hee Woo; Jiso Ryu; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

10.  Application of an autoregressive integrated moving average model for predicting the incidence of hemorrhagic fever with renal syndrome.

Authors:  Qi Li; Na-Na Guo; Zhan-Ying Han; Yan-Bo Zhang; Shun-Xiang Qi; Yong-Gang Xu; Ya-Mei Wei; Xu Han; Ying-Ying Liu
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

View more
  9 in total

1.  Mathematical model to quantify the effects of risk factors on carbapenem-resistant Acinetobacter baumannii.

Authors:  Michelle W Tan; David C Lye; Tat-Ming Ng; Michael Nikolaou; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

2.  Evaluation of phenotypic detection methods for metallo-β-lactamases (MBLs) in clinical isolates of Pseudomonas aeruginosa.

Authors:  S Peter; A Lacher; M Marschal; F Hölzl; M Buhl; I Autenrieth; M Kaase; M Willmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-23       Impact factor: 3.267

3.  Cephalosporin resistance in Neisseria gonorrhoeae infections--reply.

Authors:  Robert D Kirkcaldy; Gail A Bolan; Judith N Wasserheit
Journal:  JAMA       Date:  2013-05-15       Impact factor: 56.272

Review 4.  [Multiresistant gram-negative bacteria. A bacterial challenge of the twenty-first century].

Authors:  K Schröppel; R Riessen
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-03-13       Impact factor: 0.840

5.  Antibiotic Selection Pressure Determination through Sequence-Based Metagenomics.

Authors:  Matthias Willmann; Mohamed El-Hadidi; Daniel H Huson; Monika Schütz; Christopher Weidenmaier; Ingo B Autenrieth; Silke Peter
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

6.  Semi-Automated Visualization and ANalysis of Trends: A "SAVANT" for Facilitating Antimicrobial Stewardship Using Antistaphylococcal Resistance and Consumption as a Prototype.

Authors:  Robert J Clifford; Uzo Chukwuma; Michael E Sparks; Douglas Richesson; Charlotte V Neumann; Paige E Waterman; Jacob Moran-Gilad; Michael D Julius; Mary K Hinkle; Emil P Lesho
Journal:  Open Forum Infect Dis       Date:  2018-03-23       Impact factor: 3.835

7.  Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study.

Authors:  Matthias Willmann; Ines Kuebart; Matthias Marschal; Klaus Schröppel; Wichard Vogel; Ingo Flesch; Uwe Markert; Ingo B Autenrieth; Florian Hölzl; Silke Peter
Journal:  BMC Infect Dis       Date:  2013-11-01       Impact factor: 3.090

8.  Rapid intrinsic fluorescence method for direct identification of pathogens in blood cultures.

Authors:  John D Walsh; Jay M Hyman; Larisa Borzhemskaya; Ann Bowen; Caroline McKellar; Michael Ullery; Erin Mathias; Christopher Ronsick; John Link; Mark Wilson; Bradford Clay; Ron Robinson; Thurman Thorpe; Alex van Belkum; W Michael Dunne
Journal:  mBio       Date:  2013-11-19       Impact factor: 7.867

9.  Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study.

Authors:  Matthias Willmann; Anna M Klimek; Wichard Vogel; Jan Liese; Matthias Marschal; Ingo B Autenrieth; Silke Peter; Michael Buhl
Journal:  BMC Infect Dis       Date:  2014-12-10       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.